United states cholesterol guidelines 2001: expanded scope of intensive low-density lipoprotein–lowering therapy
- 1 October 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (7), 23-27
- https://doi.org/10.1016/s0002-9149(01)01931-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk FactorsCirculation, 2000
- Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft TrialCirculation, 2000
- Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.JAMA, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)Circulation, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of Internal Medicine, 1988